Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

13

Revenue 2014

Teva

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Teva's 2013 sales performance.

Anish Mehta appointed CEO of new women's health business

Anish Mehta appointed CEO of new women's health business

Anish Mehta appointed CEO of new women's health business. Will head up the former Teva portoflio CVC Capital Partners recently acquired. ... London-based investment firm CVC Capital Partners has appointed Anish Mehta as chief executive officer of the

Court throws out Allergan's patent deal with Native American tribe

Court throws out Allergan's patent deal with Native American tribe patients.”. Meanwhile, the decision means that generic competitors Mylan and Teva could soon be free to market a more cost-effective version of the eye drop.

CHMP recommends Teva's generic version of Astellas' Advagraf

CHMP recommends Teva's generic version of Astellas' Advagraf CHMP recommends Teva's generic version of Astellas' Advagraf. Committee backs the drug for transplant rejection prophylaxis. ... European regulatory advisors have recommended approval of Teva Pharmaceutical’s generic version of Astellas’transplant

Finalists 2017

by Teva Respiratory. with support from Teva Pharmaceuticals Inc. IMPACT – Building the Economic Case for Better Diabetes Control.

Teva faces early rival to longer-acting Copaxone in US

Teva faces early rival to longer-acting Copaxone in US Teva faces early rival to longer-acting Copaxone in US. US regulator approves Mylan’s MS drug. ... The early start of generic competition is another setback for Teva and new CEO Kåre Schultz, who has not taken up his role yet.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Solaris Health

The beauty of detail: an effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and...

Latest intelligence

Digital
Tools for the digital world
The next step for the pharma industry...
How Can We Make Payer Communications Really Sing?
With so many different influences at play in access decisions, how can we make sure we tap into what’s really driving payer decision-making. How do we go beyond the stated...
Harnessing the power of core elements to optimise market access
This article by John Spoors and Anton Abrahams focuses on optimising market access – the RJW and Solaris Health teams operate across all major markets, where the principles set out...

Infographics